AB Science SA
F:A8D
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AB Science SA
F:A8D
|
FR |
|
P
|
Paradise Co Ltd
KRX:034230
|
KR |
|
WASGAU Produktions & Handels AG
F:MSH
|
DE |
|
Openn Negotiation Ltd
ASX:OPN
|
AU |
|
Tlou Energy Ltd
ASX:TOU
|
AU |
|
Aifarm Ltd
OTC:AIFM
|
US |
|
DIOD PAO
MOEX:DIOD
|
RU |
|
Discovery Ltd
F:D3H
|
ZA |
|
IFAN Financial Inc
OTC:IFAN
|
US |
|
A
|
Aurora Eiendom AS
OSE:AURA
|
NO |
|
D
|
Daiwa Securities Group Inc
DUS:DSE
|
JP |
|
K
|
KWG Group Holdings Ltd
HKEX:1813
|
CN |
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
|
Compagnie de Saint Gobain SA
F:GOBU
|
FR |
|
H
|
Hisamitsu Pharmaceutical Co Inc
F:HPX
|
JP |
|
C
|
Country Group Holdings PCL
SET:CGH
|
TH |
|
A
|
Areeya Property PCL
SET:A
|
TH |
|
iPower Inc
NASDAQ:IPW
|
US |
|
Falco Resources Ltd
XTSX:FPC
|
CA |
|
K
|
Korea Economic Broadcasting Co Ltd
KOSDAQ:039340
|
KR |
|
Sanyo Chemical Industries Ltd
TSE:4471
|
JP |
Bankruptcy Probability
AB Science SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
AB Science SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
AB Science SA
PAR:AB
|
53m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
640B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
369.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
185.7B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
286.1B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
AB Science SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, AB Science SA has total debt of 19m EUR. This includes both short-term (2.7m EUR) and long-term (16.3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
